Clinical Trials Logo

Renal Insufficiency clinical trials

View clinical trials related to Renal Insufficiency.

Filter by:

NCT ID: NCT02194582 Active, not recruiting - Clinical trials for End Stage Renal Disease

Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure

FSGS
Start date: June 1996
Phase:
Study type: Observational

The investigators are trying to learn more about the cause of kidney diseases such as Focal Segmental Glomerulosclerosis (FSGS) and Nephrotic syndrome by studying genetics. The investigators are interested in discovering which genes play a role in causing a predisposition to FSGS/NS. The investigators also want to learn why FSGS/NS can run in families. Participation in our study involves a saliva sample and a urine sample that you can give from home. There is no cost to participate. All information is kept private and confidential. The investigators also like to include healthy volunteers (parents, spouses) if interested/available but of course this is completely optional.

NCT ID: NCT02128802 Active, not recruiting - Renal Failure Clinical Trials

Obesity Surgery and Kidney Transplant for Patients With Obesity and Renal Failure

Start date: April 2014
Phase: N/A
Study type: Interventional

Gastric Bypass followed by renal transplantation is superior to medical management followed by renal transplant for patients with severe obesity and renal failure.

NCT ID: NCT01912417 Active, not recruiting - Clinical trials for Kidney Failure, Chronic

Aerobic Exercise During Hemodialysis

Start date: August 2010
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effect of aerobic exercise during dialysis on the hemodialysis efficacy in the removal of small molecules measured by continues spend sampling of dialysate (liquid metabolites produced by the body which is disposed) technique.

NCT ID: NCT01760031 Active, not recruiting - Clinical trials for Impaired Renal Function

Longterm Follow-up After Remote Ischemic Preconditioning for Prevention of Contrast-induced Nephropathy

RenProLong
Start date: July 2012
Phase: N/A
Study type: Observational

Remote ischemic preconditioning reduces the incidence of contrast-induced acute kidney injury in patients undergoing elective coronary angiography. This study was designed to acquire long-term data of initially randomized patients in the RenPro Trial.

NCT ID: NCT01744418 Active, not recruiting - Clinical trials for Kidney Failure, Chronic

Evaluation of the Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With ESRD

Start date: November 22, 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of a novel, tissue-engineered vascular prosthesis, the Human Acellular Vascular Graft, HAVG. The HAVG is intended as an alternative to synthetic materials and to autologous grafts in the creation of vascular access for dialysis.

NCT ID: NCT01722513 Active, not recruiting - Diabetes Mellitus Clinical Trials

Efficacy and Safety of Alprostadil Prevent Contrast Induced Nephropathy

Start date: November 2012
Phase: Phase 4
Study type: Interventional

The aim of this prospective, randomized, controlled study is to investigate the effect of pretreatment with intravenous Alprostadil on the incidence of CIN in a high-risk population of patients with both type 2 diabetes mellitus (T2DM) and CKD undergoing coronary angiography, and evaluate the influence of such potential benefit on short-term outcome.

NCT ID: NCT01722383 Active, not recruiting - Clinical trials for Chronic Kidney Disease

What Are the Determinations of Adult Progressive CKD? The Renal Impairment In Secondary Care (RIISC) Study

RIISC
Start date: October 2010
Phase: N/A
Study type: Observational

Chronic kidney disease (CKD) affects up to 16% of the adult population and is associated with significant morbidity and mortality. People at highest risk from progressive CKD are defined by a sustained decline in estimated glomerular filtration rate (eGFR) and/or the presence of significant albuminuria/proteinuria. Accurate mapping of the bio-clinical determinants of this group will enable improved risk stratification and direct the development of better targeted management for people with CKD. To address these requirements we have established the Renal Impairment in Secondary Care (RIISC) study; RIISC is enrolling a cohort of patients at high risk from progressive CKD and compiling a comprehensive and detailed bio-clinical phenotype, including vascular and oral health phenotyping, at enrolment and on subsequent follow-up.

NCT ID: NCT01686191 Active, not recruiting - Clinical trials for Heart Transplantation

Genetic Predictors of Renal Dysfunction Following Heart Transplantation

Start date: August 2012
Phase:
Study type: Observational

Kidney disease is a common problem after heart transplantation. It may be caused by anti-rejection medications such as cyclosporine or tacrolimus. However, the reason why some people develop kidney problems after a heart transplant, but other people do not, is not fully known. This study plans to learn more about the relationship between a person's genetic make-up (DNA; deoxyribonucleic acid) and the risk of kidney problems after a heart transplant. The long-term goal of this research is to identify genetic variations that may help predict the development of kidney problems after heart transplantation.

NCT ID: NCT01595984 Active, not recruiting - Kidney Failure Clinical Trials

Comparison of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI)Versus a CNI-free Treatment in Renal Transplantation (CIME)

CIME
Start date: May 3, 2012
Phase: Phase 3
Study type: Interventional

The main objective of this protocol is to compare the impact on renal function of two different immunosuppressive regimens in patients with de novo renal transplant. Renal function will be accurately evaluated by measuring the clearance of iohexol. The protocol will also evaluate the efficacy and safety in a short term of these two different immunosuppressive regimens.

NCT ID: NCT01529658 Active, not recruiting - Cancer Clinical Trials

Renal Hypothermia During Partial Nephrectomy

Start date: September 2012
Phase: N/A
Study type: Interventional

The Objective is to determine if renal hypothermia during open partial nephrectomy results in improved post-operative renal function compared to warm ischemia. Primary Aim is to determine the effect of hypothermia on preservation of overall renal function compared to no hypothermia in patients who require hilar vessel clamping during open partial nephrectomy for a renal tumor. Hypothesis: Hypothermia will result in improved post-operative preservation of overall renal function. Secondary Aim is to determine the effect of hypothermia on preservation of affected renal function (kidney with the tumor) compared to no hypothermia in patients who require hilar vessel clamping during open partial nephrectomy for a renal tumor. Hypothesis: Hypothermia will result in improved post-operative preservation of affected renal function.